Elizabeth Parrish, the CEO of Bioviva USA Inc, claims to have successfully developed the anti-ageing treatment. Using the technique of gene therapy, the company claims to have reversed the effects of natural ageing.
In order to prove that the technique was safe, Parrish herself underwent gene therapy treatment which aims to put a check against muscle mass depletion and stem cell depletion which result due to various age related diseases. Parrish states that, “Current therapeutics offer only marginal benefits for people suffering from diseases of ageing. Additionally, lifestyle modification has limited impact for treating these diseases. Advances in biotechnology are the best solution, and if these results are anywhere near accurate, we’ve made history.”
However, she also mentioned the necessity of the investigation required to verify the methods.
Telomeres are the repetitive sequence of DNA present at the end of each chromosome and protect the loss of genetic material during the cell division. But, with the repetitive divisions, the telomere region becomes too short to protect the chromosomes and when this happens, the process of ageing occurs.
As per claims, the technique developed by Bioviva has successfully reversed the telomere shortening occurred in 20 years in the T-lymphocytes of 44 years old Parrish. But, the results are yet to be verified by an independent agency and meanwhile Bioviva is closely monitoring the blood of Parrish and they have to verify whether the effects can transfer to tissues of the body.